Patents of nanomaterials related with cancer treatment applications
Source abstract
Abstract
This paper reviews health-related nanomaterial patents filed in the European Patent Office. Five-year patents were examined, with a focus on cancer treatment applications. The main objective of this work is to examine key patent information in order to cover trends and determine the technological subfields that are experiencing the highest growth in cancer treatment through identifying the most commonly used nanomaterials and relationships between actors. The patenting trends indicated that key players on the field include the USA, France, Germany, the UK, and China. There is an increasing emphasis on the subject of antineoplastic agents, which is the main classification group referred by 32% of the examined patents. Gold, silica, and platinum are the most frequently cited materials in cancer treatment inventions. The patent literature paints considerably different pictures of the cancer treatment field with respect to the collaborations, or lack thereof, between different actor types.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Chemistry and Chemical Engineering · Nanotechnology research and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (26)
Show source-provided references
1. Aghebati-Maleki A, Dolati S, Ahmadi M, Baghbanzhadeh A, Asadi M, Fotouhi A, Yousefi M, Aghebati-Maleki L (2020) Nanoparticles and cancer therapy: perspectives for application of nanoparticles in the treatment of cancers. J Cell Physiol 235(3):1962–1972. https://doi.org/10.1002/jcp.2912610.1002/jcp.29126 ↗
2. An L, Wang Y, Tian Q, Yang S (2017) Small gold nanorods: recent advances in synthesis, biological imaging, and cancer therapy. Materials 10(12):1372. https://doi.org/10.3390/ma1012137210.3390/ma10121372 ↗
3. Bowerman CJ, Byrne JD, Chu KS, Schorzman AN, Keeler AW, Sherwood CA, Perry JL, Luft JC, Darr DB, Deal AM, Napier ME, Zamboni WC, Sharpless NE, Perou CM, DeSimone JM (2017) Docetaxel-loaded PLGA nanoparticles improve efficacy in taxane-resistant triple-negative breast cancer. Nano Lett 17(1):242–248. https://doi.org/10.1021/acs.nanolett.6b0397110.1021/acs.nanolett.6b03971 ↗
4. Cattaneo AG, Gornati R, Sabbioni E, Chiriva-Internati M, Cobos E, Jenkins MR, Bernardini G (2010) Nanotechnology and human health: risks and benefits. J Appl Toxicol 30(8):730–744. https://doi.org/10.1002/jat.160910.1002/jat.1609 ↗
5. Choi C, Park Y (2009) Monitoring the organic structure of technology based on the patent development paths. Technol Forecast Soc Chang 76(6):754–768. https://doi.org/10.1016/j.techfore.2008.10.00710.1016/j.techfore.2008.10.007 ↗
6. Etzkowitz H, Leydesdorff L (2000) The dynamics of innovation: from National Systems and ‘mode 2’ to a triple helix of university–industry–government relations. Res Policy 29(2):109–123. https://doi.org/10.1016/S0048-7333(99)00055-410.1016/S0048-7333(99)00055-4 ↗
7. Fini R, Grimaldi R, Santoni S, Sobrero M (2011) Complements or substitutes? The role of universities and local context in supporting the creation of academic spin-offs. Res Policy 40(8):1113–1127. https://doi.org/10.1016/j.respol.2011.05.01310.1016/j.respol.2011.05.013 ↗
8. Firat AK, Woon WL, Madnick S (2008) Technological forecasting – a review, Composite Information Systems Laboratory (CISL) Sloan School of Management, Room E53–320 Massachusetts Institute of Technology Cambridge, MA 02142
9. W. Glänzel, H. F. Moed, U. Schmoch, and M. Thelwall, Springer handbook of science and technology indicators. 201910.1007/978-3-030-02511-3 ↗
10. Huang Z, Chen H, Yip A, Ng G, Guo F, Chen ZK, Roco MC (2003) No title found. J Nanopart Res 5(3/4):333–363. https://doi.org/10.1023/A:102555680099410.1023/A:1025556800994 ↗
11. Hunter R, Preedy VR (2011) Nanomedicine in health and disease. CRC Press, Boca Raton10.1201/b11076 ↗
12. Islam N, Miyazaki K (2009) Nanotechnology innovation system: understanding hidden dynamics of nanoscience fusion trajectories. Technol Forecast Soc Chang 76(1):128–140. https://doi.org/10.1016/j.techfore.2008.03.02110.1016/j.techfore.2008.03.021 ↗
13. Lee C, Jeon J, Park Y (2011) Monitoring trends of technological changes based on the dynamic patent lattice: a modified formal concept analysis approach. Technol Forecast Soc Chang 78(4):690–702. https://doi.org/10.1016/j.techfore.2010.11.01010.1016/j.techfore.2010.11.010 ↗
14. Li Z, Huang H, Tang S, Li Y, Yu XF, Wang H, Li P, Sun Z, Zhang H, Liu C, Chu PK (2016) Small gold nanorods laden macrophages for enhanced tumor coverage in photothermal therapy. Biomaterials 74:144–154. https://doi.org/10.1016/j.biomaterials.2015.09.03810.1016/j.biomaterials.2015.09.038 ↗
15. Linton JD, Walsh ST (2008) A theory of innovation for process-based innovations such as nanotechnology. Technol Forecast Soc Chang 75(5):583–594. https://doi.org/10.1016/j.techfore.2007.02.00510.1016/j.techfore.2007.02.005 ↗
16. B. D. Malhotra Md. A. Ali, Nanomaterials for biosensors: fundamentals and applications. 201810.1016/B978-0-323-44923-6.00001-7 ↗
17. Marco AC, Sarnoff JD, deGrazia CAW (2019) Patent claims and patent scope. Res Policy 48(9):103790. https://doi.org/10.1016/j.respol.2019.04.01410.1016/j.respol.2019.04.014 ↗
18. Navya PN, Kaphle A, Daima HK (2018) Nanomedicine in sensing, delivery, imaging and tissue engineering: advances, opportunities and challenges. In: Thomas PJ, Revaprasadu N (eds) Nanoscience, vol 5. Royal Society of Chemistry, Cambridge, pp 30–5610.1039/9781788013871-00030 ↗
19. Navya PN, Madhyastha H, Madhyastha R, Nakajima Y, Maruyama M, Srinivas SP, Jain D, Amin MH, Bhargava SK, Daima HK (2019) Single step formation of biocompatible bimetallic alloy nanoparticles of gold and silver using isonicotinylhydrazide. Mater Sci Eng C 96:286–294. https://doi.org/10.1016/j.msec.2018.11.02410.1016/j.msec.2018.11.024 ↗
20. Patel S, Nanda R (2015) Nanotechnology in healthcare: applications and challenges. Med Chem 05(12). https://doi.org/10.4172/2161-0444.100031210.4172/2161-0444.1000312 ↗
21. PATSTAT Online (Beta) (n.d.) European Patent Office. http://www.epo.org/searching/subscription/patstat-online.html . Accessed Jul. 01, 2015
22. Porter AL, Cunningham SW (2005) Tech mining: exploiting new technologies for competitive advantage. Wiley, Hoboken
23. Quader S, Kataoka K (2017) Nanomaterial-enabled Cancer therapy. Mol Ther 25(7):1501–1513. https://doi.org/10.1016/j.ymthe.2017.04.02610.1016/j.ymthe.2017.04.026 ↗
24. Shi J, Votruba AR, Farokhzad OC, Langer R (2010) Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 10(9):3223–3230. https://doi.org/10.1021/nl102184c10.1021/nl102184c ↗
25. Sorenson O, Rivkin JW, Fleming L (2006) Complexity, networks and knowledge flow. Res Policy 35(7):994–1017. https://doi.org/10.1016/j.respol.2006.05.00210.1016/j.respol.2006.05.002 ↗
26. Wu L, Zhu H, Chen H, Roco MC (2019) Comparing nanotechnology landscapes in the US and China: a patent analysis perspective. J Nanopart Res 21(8):8. https://doi.org/10.1007/s11051-019-4608-010.1007/s11051-019-4608-0 ↗